Mirati Therapeutics Inc (NASDAQ:MRTX)

BATS BZX Real-Time Price
As of 12:52pm ET
 +3.75 / +3.29%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for Mirati Therapeutics Inc have a median target of 212.00, with a high estimate of 300.00 and a low estimate of 171.00. The median estimate represents a +79.97% increase from the last price of 117.80.

Analyst Recommendations

The current consensus among 16 polled investment analysts is to Buy stock in Mirati Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -91.45%
Growthannually -32.32%


Growthquarterly -97.76%
Growthannually 409.04%
Key to the earnings and sales forecast charts.